期刊文献+

维思通与其他抗精神病药物副作用对照研究的Mata分析 被引量:7

Meta - analysis of control studies on side effects of risperidone and other antipsychotks
下载PDF
导出
摘要 目的 进一步了解维思通与其他抗精神病药物副作应的差异。方法 按标准对收集的16篇关于维思通与其他抗精神病药物导致副作用的论文进行Meta分析。结果(1)维思通与其他抗精神病药物导致副作用显著不同,维思通以肌强直、静坐不静、失眠焦虑为主,而其他抗精神病药物以便秘、心动过速、视力模糊、流涎、嗜睡、头昏、记忆下降、WBC下降为主。(2)维思通所致副作用的效应(ES)比较低,ES=0.12~0.33,而其他抗精神病药物导致的其他副作用的效应比较明显,ES=0.52~0.78。(3)归因分析发现维思通导致的副作用肌强直、静坐不能、震颤、失眠焦虑是其他抗精神病药物的2.53~4.54倍,而其他抗精神病药物导致的其他副作用是维思通的2.51~7.78倍。结论 维思通与其他抗精神病药物导致的副作用显著不同,除效应较小的肌强直、静坐不能、失眠焦虑外几乎没有其他副反应。 Objective To understand the difference in incidence of side effects of risperidone and other antipsychot-ics. Methods Meta - analysis was done for papers on incidence of side effects induced by risperidone and other antip-sychotics. Results It was found that difference in incidence of side effects by risperidone (dystonia, akathisia, insomnia anxiety) and other antipsychotics (constipation, tachycardia, blurred vision, salivate, drowsiness,dizziness,memory disterbance, leukopenia) was significant. The effect size(ES)of side effects by risperidone was between 0.12 and 0.33, other antipsychotics between 0.52 and 0.78. The incidence of dystonia,akathisia, tremor and insomnia anxiety induced by risperidone was 2.53-4.54 folds of that by other antipsychotics, and incidence of constipation, tachycardia, blurred vision, salivate, drowsiness, dizziness, memory disterbance, hypotension, alteration of EKG and leukopenia induced by other antipsychotics was 2.51-7.78 folds of that by risperidone. Conclusion There was significant difference in incidence of different side effects by risperidone and other antipsychotics. Risperidone was characterized by little side effects except extrapyramidal symptoms (EPS) with light effect size.
出处 《山东精神医学》 2001年第2期78-83,共6页 Shangdong Archives of Psychiatry
关键词 维思通 抗精神病药物 副作用 META分析 Risperidone Antipsychotics Side effect Meta - analysis
  • 相关文献

参考文献18

二级参考文献29

  • 1曾昭祥,李志成,刘琳,张昭才,王东坡,何秀俊,金卫东,王高华,刘仁刚.氯氮平与氯丙嗪对心电图影响的比较[J].临床精神医学杂志,1994,4(3):158-160. 被引量:14
  • 2金卫东,刘仁刚,臧德馨,王超英.再分析法评定Ⅰ、Ⅱ型精神分裂症家族史的差异[J].中国神经精神疾病杂志,1994,20(4):236-237. 被引量:2
  • 3金卫东.数理精神医学:(三)Meta分析[J].四川精神卫生,1996,9(1):62-63. 被引量:26
  • 4张聪沛.维思通与氯氮平治疗精神分裂症对照研究[J].临床精神医学杂志,1997,7:24-24.
  • 5沈渔村.精神医学(第3版)[M].北京:人民卫生出版社,1994.945.
  • 6于欣 侯也之 等.利培酮治疗精神分裂症的开放性验证[J].中华精神科杂志,1997,30:79-79.
  • 7陈爱琴 赵友文 等.舒必利治疗焦滤抑郁症状的疗效分析[J].中华神经精神科杂志,1994,4:220-220.
  • 8喻东山.维思通和氯氮平的副反应对比[J].临床精神医学杂志,1998,8:63-63.
  • 9[2]Heinrich K,Klieser E,Lehmann E et al.Risperidone versus clozapine in the treatment of schizophrenic patients with acute symptoms.Prog Neuropsychopharmacol Biol Psychiatry,1994; 18:129
  • 10[5]Marder S R,Meibach R C.Risperidone in the treatment of schizophrenia.Am J Psychiary,1994,151:825~835

共引文献258

同被引文献48

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部